Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
1,2,3-Triazole-Isoxazole Based Acetylcholinesterase Inhibitors: Synthesis, Biological Evaluation and Docking Study Publisher



Najafi Z1, 2 ; Mahdavi M3 ; Saeedi M4, 5 ; Sabourian R5 ; Khanavi M6 ; Safavi M7 ; Tehrani MB2 ; Shafiee A8 ; Foroumadi A8 ; Akbarzadeh T2, 5
Authors

Source: Letters in Drug Design and Discovery Published:2017


Abstract

In this work, a series of derivatives containing 1,2,3-triazole and isoxazole were synthesized. All of them were evaluated as novel dual AChE inhibitors. Most of synthesized compounds showed moderate to good inhibitory potency toward AChE. Among them, N-((1-(4-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)-5-(p-tolyl)isoxazole-3-carboxamide (5m) was the most potent AChE inhibitor, being 12-fold more potent than rivastigmine, as the reference drug. Also, molecular modeling revealed that compound 5m targeted both the catalytic anionic site (CAS) and the peripheral anionic site (PAS) of AChE. ©2017 Bentham Science Publishers.
Other Related Docs